Literature DB >> 1916050

Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin.

J C Sodoyez1, M Koch, I Lemaire, F Sodoyez-Goffaux, A Rapaille, C François-Gérard, D Sondag.   

Abstract

Hybridomas producing proinsulin antibodies were cloned by limiting dilution of cell cultures obtained by fusion of splenocytes of immunized mice with immortal myeloma cells. Some proinsulin monoclonal antibodies crossreacted with labelled insulin but none did with labelled C-peptide indicating that the involved epitopes were at one of the insulin/C-peptide junctions or included in the insulin moiety. Hybridoma supernatants were assayed for IgG concentration by a solid phase assay and for ligand binding by a radiobinding assay and an enzyme linked immunosorbent assay. The half-life of immune complexes formed with radioligand was measured and, as expected, correlated with affinity as measured by the method of Scatchard. Antibody titres determined by enzyme linked immunosorbent assay did not correlate to those measured by radiobinding assay. IgG concentration correlated to enzyme linked immunosorbent assay titres but not to radiobinding assay titres. Finally, a significant correlation was found between radiobinding assay titre and the product of enzyme linked immunosorbent assay titre by the period of immune complexes. It is concluded that, except for very low affinity antibodies, enzyme linked immunosorbent assay is a capacity assay whereas radiobinding assay is influenced by both antibody concentration and affinity. The former assay is thus best suited to detecting low affinity antibodies whereas the latter is more efficient in the presence of low levels of high affinity antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916050     DOI: 10.1007/bf00403281

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children.

Authors:  C Levy-Marchal; M P Bridel; F Sodoyez-Goffaux; M Koch; J Tichet; P Czernichow; J C Sodoyez
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

2.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease.

Authors:  Y Hirata; M Tominaga; J I Ito; A Noguchi
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

Review 4.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Rat (and mouse) monoclonal antibodies. VIII. ELISA measurement of Ig production in mouse hybridoma culture supernatants.

Authors:  T Delaunay; J Louahed; H Bazin
Journal:  J Immunol Methods       Date:  1990-07-20       Impact factor: 2.303

6.  Clonally restricted insulin autoantibodies in a cohort of 2200 healthy blood donors.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; M Koch; D Sondag; C Bouillenne; C François-Gérard; E Bosi
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

7.  Clinical and biochemical aspects of the insulin autoimmune syndrome (IAIS).

Authors:  G Trenn; V Eysselein; H U Mellinghoff; R Müller; G Benker; D Reinwein; K Federlin
Journal:  Klin Wochenschr       Date:  1986-10-01

8.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

9.  Insulin antibodies in patients receiving penicillamine.

Authors:  E A Benson; L A Healey; E J Barron
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

10.  Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody.

Authors:  L J Nell; V J Virta; J W Thomas
Journal:  Diabetes       Date:  1985-01       Impact factor: 9.461

View more
  4 in total

Review 1.  Antigen-specific responses in autoimmunity and tolerance.

Authors:  J W Thomas
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

3.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

4.  Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Authors:  Luciano Lucas Guerra; Natalia Inés Faccinetti; Aldana Trabucchi; Bruno David Rovitto; Adriana Victoria Sabljic; Edgardo Poskus; Ruben Francisco Iacono; Silvina Noemí Valdez
Journal:  BMC Biotechnol       Date:  2016-11-24       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.